ORIC Pharmaceuticals, Inc. Share Price Börse Stuttgart
Stocks
4TZ
US68622P1093
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
10:17:12 22/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 11.30 EUR | +2.96% |
|
+1.39% | +59.06% |
| Market Cap | 139.93Cr 122.29Cr 114.93Cr 104.88Cr 196.85Cr 13TCr 196.88Cr 1.38TCr 532.27Cr 6.83TCr 525.5Cr 513.98Cr 22TCr | P/E 2026 * |
-8.88x | P/E 2027 * | -8.07x |
|---|---|---|---|---|---|
| Enterprise Value | 139.93Cr 122.29Cr 114.93Cr 104.88Cr 196.85Cr 13TCr 196.88Cr 1.38TCr 532.27Cr 6.83TCr 525.5Cr 513.98Cr 22TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
98.41% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ORIC | Delayed | |
CBOE
| ORIC | Real-time | |
|
Deutsche Boerse AG
| 4TZ | Delayed | |
|
Börse Stuttgart
| 4TZ | Delayed | |
|
Tradegate
| 4TZ | Real-time | |
|
Boerse Muenchen
| 4TZ | Real-time |
Last Transcript: ORIC Pharmaceuticals, Inc.
| 1 week | +6.50% | ||
| Current month | +1.76% | ||
| 1 month | -6.26% | ||
| 3 months | +46.26% | ||
| 6 months | +20.86% | ||
| Current year | +63.77% |
| 1 week | 10.52 |  | 11.46 |
| 1 month | 10.12 | | 12.1 |
| 3 years | 3.7 | | 14.9 |
| 5 years | 2.2 | | 20.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 47 | 07/05/2018 |
| Director of Finance/CFO | 52 | 01/09/2019 | |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 18/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Heyman
CHM | Chairman | 68 | 07/03/2018 |
Jacob Chacko
BRD | Director/Board Member | 47 | 07/05/2018 |
Mardi Dier
BRD | Director/Board Member | 62 | 01/02/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.96% | +1.39% | +24.18% | +54.79% | 131.33Cr | |
| -0.07% | +7.14% | +53.95% | +111.00% | 7.43TCr | |
| -1.45% | -0.40% | +35.52% | +79.18% | 6.23TCr | |
| -0.66% | +6.97% | +31.36% | +23.45% | 2.77TCr | |
| -0.15% | +0.75% | -16.69% | +361.67% | 2.64TCr | |
| +2.93% | +4.32% | +2.18% | -3.60% | 2.46TCr | |
| +0.84% | +6.00% | +25.53% | -9.89% | 2.07TCr | |
| +0.87% | -3.73% | +159.95% | +327.53% | 1.5TCr | |
| +1.63% | +2.20% | +46.92% | +170.72% | 1.42TCr | |
| +1.30% | -1.61% | -10.37% | +815.51% | 1.35TCr | |
| Average | +0.58% | +1.94% | +35.25% | +193.04% | 3.1TCr | |
| Weighted average by Cap. | +0.09% | +2.74% | +36.39% | +148.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -17Cr -15Cr -14Cr -12Cr -23Cr -1.59TCr -23Cr -164.26Cr -63Cr -813.47Cr -63Cr -61Cr -2.62TCr | -20Cr -17Cr -16Cr -15Cr -28Cr -1.91TCr -28Cr -197.29Cr -76Cr -977.07Cr -75Cr -74Cr -3.15TCr |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 22/26/22 | €11.30 | +2.96% |
| 21/26/21 | €10.98 | 0.00% |
| 18/26/18 | €10.98 | -1.53% |
| 17/26/17 | €11.15 | +2.62% |
| 16/26/16 | €10.86 | +2.36% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORIC Stock
- 4TZ Stock
Select your edition
All financial news and data tailored to specific country editions
